Related Experiment Videos

[Alpha-1-antitrypsin in the newborn with idiopathic respiratory distress syndrome]

Insights

Newborns with respiratory distress syndrome (RDS) have lower plasma alpha-1-antitrypsin (a-l-AT) and protein levels at 24 hours. Levels increase by 72 hours, suggesting a-l-AT quantification aids RDS diagnosis.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Pulmonary Medicine

Background:

  • Respiratory Distress Syndrome (RDS) is a significant cause of morbidity and mortality in newborns.
  • Plasma protein levels, including alpha-1-antitrypsin (a-l-AT), may be altered in neonatal conditions.
  • Understanding these biochemical markers is crucial for early diagnosis and management of RDS.

Purpose of the Study:

  • To investigate the plasma concentrations of alpha-1-antitrypsin (a-l-AT) and total proteins in newborns with RDS.
  • To compare these concentrations with those in healthy control infants.
  • To evaluate the diagnostic utility of a-l-AT quantification for RDS.

Main Methods:

  • Plasma samples were collected from 50 newborns diagnosed with RDS and 41 healthy controls.
  • Blood samples were analyzed at three time points: 24, 72, and 120 postnatal hours.
  • Concentrations of a-l-AT and total proteins were measured using established biochemical assays.

Main Results:

  • At 24 hours postnatal, infants with RDS exhibited significantly lower plasma a-l-AT (187.5 +/- 9 mg/dl) and total protein (4.15 +/- 0.09 g.%) levels compared to controls.
  • By 72 hours, a-l-AT and total protein concentrations increased in the RDS group, while control levels remained stable.
  • A decrease in total protein was partly attributed to a reduction in the globulin fraction.

Conclusions:

  • Plasma a-l-AT and total protein levels are significantly reduced in newborns with RDS during the early postnatal period.
  • The dynamic changes in these protein concentrations over the first 72 hours of life may reflect disease progression or recovery.
  • Quantification of plasma a-l-AT shows potential as a valuable diagnostic biomarker for Respiratory Distress Syndrome in neonates.

Related Concept Videos